Two West Coast companies – Pascal Biosciences and SoRSE Technology – are collaborating to move the cannabinoid PAS-393 into clinical trials to test the drug’s effectiveness on a common immune-evading strategy that many metastatic cancers em…
Wednesday, June 23, 2021
CBD News, Info and Links